Authors:
Nicolaou, KC
Namoto, K
Li, J
Ritzen, A
Ulven, T
Shoji, M
Zaharevitz, D
Gussio, R
Sackett, DL
Ward, RD
Hensler, A
Fojo, T
Giannakakou, P
Citation: Kc. Nicolaou et al., Synthesis and biological evaluation of 12,13-cyclopropyl and 12,13-cyclobutyl epothilones, CHEMBIOCHEM, 2(1), 2001, pp. 69-75
Authors:
Kunick, C
Schultz, C
Lemcke, T
Zaharevitz, DW
Gussio, R
Jalluri, RK
Sausville, EA
Leost, M
Meijer, L
Citation: C. Kunick et al., 2-substituted paullones: CDK1/cyclin B-inhibiting property and in vitro antiproliferative activity, BIOORG MED, 10(6), 2000, pp. 567-569
Authors:
Gussio, R
Zaharevitz, DW
McGrath, CF
Pattabiraman, N
Kellogg, GE
Schultz, C
Link, A
Kunick, C
Leost, M
Meijer, L
Sausville, EA
Citation: R. Gussio et al., Structure-based design modifications of the paullone molecular scaffold for cyclin-dependent kinase inhibition, ANTI-CAN DR, 15(1), 2000, pp. 53-66
Authors:
Giannakakou, P
Gussio, R
Nogales, E
Downing, KH
Zaharevitz, D
Bollbuck, B
Poy, G
Sackett, D
Nicolaou, KC
Fojo, T
Citation: P. Giannakakou et al., A common pharmacophore for epothilone and taxanes: Molecular basis for drug resistance conferred by tubulin mutations in human cancer cells, P NAS US, 97(6), 2000, pp. 2904-2909
Authors:
Leost, M
Schultz, C
Link, A
Wu, YZ
Biernat, J
Mandelkow, EM
Bibb, JA
Snyder, GL
Greengard, P
Zaharevitz, DW
Gussio, R
Senderowicz, AM
Sausville, EA
Kunick, C
Meijer, L
Citation: M. Leost et al., Paullones are potent inhibitors of glycogen synthase kinase-3 beta and cyclin-dependent kinase 5/p25, EUR J BIOCH, 267(19), 2000, pp. 5983-5994
Authors:
Zaharevitz, DW
Gussio, R
Wiegand, A
Jalluri, R
Pattabiraman, N
Kellogg, GE
Pallansch, LA
Yang, SS
Buckheit, RW
Citation: Dw. Zaharevitz et al., Discovery of novel HIV-1 reverse transcriptase inhibitors using a combination of 3D database searching and 3D QSAR, MED CHEM RE, 9(7-8), 1999, pp. 551-564
Authors:
Sausville, EA
Zaharevitz, D
Gussio, R
Meijer, L
Louarn-Leost, M
Kunick, C
Schultz, R
Lahusen, T
Headlee, D
Stinson, S
Arbuck, SG
Senderowicz, A
Citation: Ea. Sausville et al., Cyclin-dependent kinases: Initial approaches to exploit a novel therapeutic target, PHARM THERA, 82(2-3), 1999, pp. 285-292
Authors:
Schultz, C
Link, A
Leost, M
Zaharevitz, DW
Gussio, R
Sausville, EA
Meijer, L
Kunick, C
Citation: C. Schultz et al., Paullones, a series of cyclin-dependent kinase inhibitors: Synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity, J MED CHEM, 42(15), 1999, pp. 2909-2919
Authors:
Zaharevitz, DW
Gussio, R
Leost, M
Senderowicz, AM
Lahusen, T
Kunick, C
Meijer, L
Sausville, EA
Citation: Dw. Zaharevitz et al., Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases, CANCER RES, 59(11), 1999, pp. 2566-2569